AI assistant
Sending…
ORAGENICS INC — Director's Dealing 2008
Feb 11, 2008
35380_dirs_2008-02-11_5f757b9a-b0c3-4a1e-bbf8-7edc08336d48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (oni)
CIK: 0001174940
Period of Report: 2008-02-08
Reporting Person: HAWES GEORGE T (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-08 | warrants | $0.44 | P | 150000 | Acquired | 2008-02-08 | common stock (150000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| common stock | 5275767 | Direct |
| common stock | 105000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| warrants | $0.44 | 2008-08-08 | common stock (1100000) | 1100000 | Direct |
| Non-employee director options | $0.74 | 2011-09-08 | common stock (65000) | 65000 | Direct |
| warrants | $0.44 | 2008-08-08 | common stock (100000) | 100000 | Indirect |
Footnotes
F1: The exercise price per share is $0.44 until February 29, 2008, after which the exercise price per share becomes $0.58 for the remainder of the warrant term.
More from ORAGENICS INC
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Jan 22
Capital/Financing Update
2026
Jan 22